CAMBRIDGE, Mass., May 23, 2024
/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq:
AKBA), a biopharmaceutical company with the purpose to better the
lives of people impacted by kidney disease, today announced that
John Butler, Chief Executive
Officer, will present at the Jefferies Global Healthcare Conference
on Wednesday, June 5 at 9:00 a.m. ET.
The Jefferies Global Healthcare Conference will take place in
New York, NY on June 4-6, 2024.
A webcast of the presentation can be accessed through the
"Investors" section of Akebia's website at https://ir.akebia.com
for 30 days following the conference.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. Akebia was
founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-jefferies-global-healthcare-conference-302153546.html
SOURCE Akebia Therapeutics, Inc.